Related references
Note: Only part of the references are listed.Limiting access to iron decreases infection of Atlantic salmon SHK-1 cells with bacterium Piscirickettsia salmonis
Rodrigo Diaz et al.
BMC VETERINARY RESEARCH (2021)
Iron overload inhibits BMP/SMAD and IL-6/STAT3 signaling to hepcidin in cultured hepatocytes
Edouard Charlebois et al.
PLOS ONE (2021)
Hepcidin-to-Ferritin Ratio Is Decreased in Astrocytes With Extracellular Alpha-Synuclein and Iron Exposure
Juntao Cui et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Combined locoregional-immunotherapy for liver cancer
Tim F. Greten et al.
JOURNAL OF HEPATOLOGY (2019)
A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors
Kabir Mody et al.
INVESTIGATIONAL NEW DRUGS (2019)
New insights into functions of the sphingosine-1-phosphate transporter SPNS2
Sarah Spiegel et al.
JOURNAL OF LIPID RESEARCH (2019)
Hepcidin and DNA promoter methylation in hepatocellular carcinoma
Silvia Udali et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
Lewis R. Roberts et al.
HEPATOLOGY (2018)
Iron and Cancer
Suzy V. Torti et al.
ANNUAL REVIEW OF NUTRITION, VOL 38 (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Iron metabolism gene expression and prognostic features of hepatocellular carcinoma
Ying Shen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Metastatic growth instructed by neutrophil-derived transferrin
Wei Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Iron in the Tumor Microenvironment-Connecting the Dots
Christa Pfeifhofer-Obermair et al.
FRONTIERS IN ONCOLOGY (2018)
Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine
Chang-quan Ling et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2018)
Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors
Mayuko Furuta et al.
JOURNAL OF HEPATOLOGY (2017)
miR-212 mediates counter-regulation on CRH expression and HPA axis activity in male mice
Yuxiao Tang et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
Genome-wide in vivo screen identifies novel host regulators of metastatic colonization
Louise van der Weyden et al.
NATURE (2017)
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
Gonzalo Sapisochin et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Sphingosine 1-phosphate signaling through its receptor S1P5 promotes chromosome segregation and mitotic progression
Guillaume Andrieu et al.
SCIENCE SIGNALING (2017)
Sphingosine 1-phosphate signaling through its receptor S1P5 promotes chromosome segregation and mitotic progression
Guillaume Andrieu et al.
SCIENCE SIGNALING (2017)
Phase I Trial of TriapineCisplatin-Paclitaxel Chemotherapy for advanced Stage or Metastatic Solid Tumor Cancers
Charles A. Kunos et al.
FRONTIERS IN ONCOLOGY (2017)
The hepatocyte- specific HNF4α/miR-122 pathway contributes to iron overload-mediated hepatic inflammation
Min Li et al.
BLOOD (2017)
miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis
Shao-Lai Zhou et al.
HEPATOLOGY (2016)
Hypoxic control of metastasis
Erinn B. Rankin et al.
SCIENCE (2016)
Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth facetor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion
Mohamad M. Adada et al.
FASEB JOURNAL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Prevalence of neutralizing antibodies against liver-tropic adeno-associated virus serotype vectors in 100 healthy Chinese and its potential relation to body constitutions
Chen Ling et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2015)
Bone metastases in hepatocellular carcinoma: an emerging issue
Vito Longo et al.
CANCER AND METASTASIS REVIEWS (2014)
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
Christophe Louandre et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Iron and cancer: more ore to be mined
Suzy V. Torti et al.
NATURE REVIEWS CANCER (2013)
Iron overload in non-transfusion-dependent thalassemia: a clinical perspective
Khaled M. Musallam et al.
BLOOD REVIEWS (2012)
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Shu-hao Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Wei-Chih Tsai et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Hepatic iron stores are increased as assessed by magnetic resonance imaging in a Chinese population with altered glucose homeostasis
Xuan Zheng et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Iron Deprivation Suppresses Hepatocellular Carcinoma Growth in Experimental Studies
Qian Ba et al.
CLINICAL CANCER RESEARCH (2011)
Deferoxamine for Advanced Hepatocellular Carcinoma
Takahiro Yamasaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
Zandra K. Pinnix et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The Sphingolipid Transporter Spns2 Functions in Migration of Zebrafish Myocardial Precursors
Atsuo Kawahara et al.
SCIENCE (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
M Elmberg et al.
GASTROENTEROLOGY (2003)